相似文献
1
Inflammation and Colorectal Cancer.
Curr Colorectal Cancer Rep. 2017 Aug;13(4):341-351. doi: 10.1007/s11888-017-0373-6. Epub 2017 Jun 17.
2
Colorectal cancer in inflammatory bowel disease: what is the real magnitude of the risk?
World J Gastroenterol. 2012 Aug 7;18(29):3839-48. doi: 10.3748/wjg.v18.i29.3839.
3
Role of Inflammation in the Development of Colorectal Cancer.
Endocr Metab Immune Disord Drug Targets. 2021;21(1):77-90. doi: 10.2174/1871530320666200909092908.
4
Patient-derived Colonoids From Disease-spared Tissue Retain Inflammatory Bowel Disease-specific Transcriptomic Signatures.
Gastro Hep Adv. 2023;2(6):830-842. doi: 10.1016/j.gastha.2023.05.003. Epub 2023 May 25.
5
Colorectal Cancer in Inflammatory Bowel Disease: Epidemiology, Pathogenesis and Surveillance.
Gastrointest Tumors. 2014 Aug;1(3):146-54. doi: 10.1159/000365309. Epub 2014 Jul 18.
6
Advances in molecular mechanisms of inflammatory bowel disease‑associated colorectal cancer (Review).
Oncol Lett. 2024 Apr 9;27(6):257. doi: 10.3892/ol.2024.14390. eCollection 2024 Jun.
7
Colonoids From Patients With Pediatric Inflammatory Bowel Disease Exhibit Decreased Growth Associated With Inflammation Severity and Durable Upregulation of Antigen Presentation Genes.
Inflamm Bowel Dis. 2021 Jan 19;27(2):256-267. doi: 10.1093/ibd/izaa145.
8
Molecular Alterations of Colorectal Cancer with Inflammatory Bowel Disease.
Dig Dis Sci. 2015 Aug;60(8):2251-63. doi: 10.1007/s10620-015-3646-4. Epub 2015 Apr 4.
9
Novel Biomarkers for Inflammatory Bowel Disease and Colorectal Cancer: An Interplay between Metabolic Dysregulation and Excessive Inflammation.
Int J Mol Sci. 2023 Mar 22;24(6):5967. doi: 10.3390/ijms24065967.
10
The outcome of patients with inflammatory bowel disease-associated colorectal cancer is not worse than that of patients with sporadic colorectal cancer-a matched-pair analysis of survival.
Int J Colorectal Dis. 2022 Feb;37(2):381-391. doi: 10.1007/s00384-021-04072-9. Epub 2021 Dec 4.
引用本文的文献
1
Targeting cytokine and chemokine signaling pathways for enhancing chemo-sensitivity in colorectal cancer.
Cell Commun Signal. 2025 Aug 12;23(1):369. doi: 10.1186/s12964-025-02235-7.
2
Physical exercise as a potential adjuvant therapy: effects on inflammation and nutrition in colorectal cancer patients-a systematic review and meta-analysis.
Front Nutr. 2025 Jun 26;12:1612674. doi: 10.3389/fnut.2025.1612674. eCollection 2025.
3
Deciphering the metabolic landscape of colorectal cancer through the lens of AhR-mediated intestinal inflammation.
Discov Oncol. 2025 Mar 7;16(1):275. doi: 10.1007/s12672-025-01949-x.
4
Cascade loop of ferroptosis induction and immunotherapy based on metal-phenolic networks for combined therapy of colorectal cancer.
Exploration (Beijing). 2024 May 15;5(1):20230117. doi: 10.1002/EXP.20230117. eCollection 2025 Feb.
5
Biomarkers of inflammation and colorectal cancer risk.
Front Oncol. 2025 Feb 6;15:1514009. doi: 10.3389/fonc.2025.1514009. eCollection 2025.
6
Integrin α3β1 Is Not Required for Onset of Dysplasia in Genetic Model of Colon Cancer but Promotes Motility of Colon Cancer Cells.
Cancers (Basel). 2025 Jan 23;17(3):371. doi: 10.3390/cancers17030371.
7
Pre-diagnostic 25-hydroxyvitamin D levels and subsite-specific colorectal cancer risk: a nested case-control study from the Norwegian Women and Cancer Study (NOWAC).
Br J Nutr. 2025 Jan 3;133(3):1-9. doi: 10.1017/S0007114524003350.
8
Involvement of platelet signaling pathways in colorectal cancer and new therapeutic targets.
Am J Cancer Res. 2024 Nov 15;14(11):5133-5153. doi: 10.62347/PJNU8987. eCollection 2024.
9
The association between non- and pro-healthy diet indices and the risk of colorectal cancer: a case-control study.
BMC Gastroenterol. 2024 Nov 21;24(1):419. doi: 10.1186/s12876-024-03520-4.
10
Some Glycoproteins Expressed on the Surface of Immune Cells and Cytokine Plasma Levels Can Be Used as Potential Biomarkers in Patients with Colorectal Cancer.
Biomolecules. 2024 Oct 16;14(10):1314. doi: 10.3390/biom14101314.
本文引用的文献
1
Increased transforming growth factor β and interleukin 10 transcripts in peripheral blood mononuclear cells of colorectal cancer patients.
Contemp Oncol (Pozn). 2016;20(6):458-462. doi: 10.5114/wo.2016.65605. Epub 2017 Jan 12.
2
Inactivation of Interferon Receptor Promotes the Establishment of Immune Privileged Tumor Microenvironment.
Cancer Cell. 2017 Feb 13;31(2):194-207. doi: 10.1016/j.ccell.2017.01.004.
3
Defective IL-23/IL-17 Axis Protects p47phox-/- Mice from Colon Cancer.
Front Immunol. 2017 Jan 27;8:44. doi: 10.3389/fimmu.2017.00044. eCollection 2017.
4
Organoid Culture of Isolated Cells from Patient-derived Tissues with Colorectal Cancer.
Chin Med J (Engl). 2016 Oct 20;129(20):2469-2475. doi: 10.4103/0366-6999.191782.
5
Colorectal Cancer and Dysplasia in Inflammatory Bowel Disease: A Review of Disease Epidemiology, Pathophysiology, and Management.
Cancer Prev Res (Phila). 2016 Dec;9(12):887-894. doi: 10.1158/1940-6207.CAPR-16-0124. Epub 2016 Sep 27.
6
Organoids as a Model for Colorectal Cancer.
Curr Colorectal Cancer Rep. 2016;12(5):281-287. doi: 10.1007/s11888-016-0335-4. Epub 2016 Aug 6.
7
Control of Paneth Cell Fate, Intestinal Inflammation, and Tumorigenesis by PKCλ/ι.
Cell Rep. 2016 Sep 20;16(12):3297-3310. doi: 10.1016/j.celrep.2016.08.054.
8
RSPO3 expands intestinal stem cell and niche compartments and drives tumorigenesis.
Gut. 2017 Jun;66(6):1095-1105. doi: 10.1136/gutjnl-2016-311606. Epub 2016 Aug 10.
9
Molecular Subtypes and Personalized Therapy in Metastatic Colorectal Cancer.
Curr Colorectal Cancer Rep. 2016;12:141-150. doi: 10.1007/s11888-016-0312-y. Epub 2016 Apr 18.
10
Molecular pathological classification of colorectal cancer.
Virchows Arch. 2016 Aug;469(2):125-34. doi: 10.1007/s00428-016-1956-3. Epub 2016 Jun 20.
Zotero 插件